BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdallah Y, Gligorievski D, Kasseckert SA, Dieterich L, Schäfer M, Kuhlmann CR, Noll T, Sauer H, Piper HM, Schäfer C. The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia. Cardiovasc Res. 2007;73:568-574. [PMID: 17196568 DOI: 10.1016/j.cardiores.2006.11.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Polhemus DJ, Lefer DJ. Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease. Circ Res 2018;123:590-600. [PMID: 30355137 DOI: 10.1161/CIRCRESAHA.118.311134] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
2 Härtel FV, Holl M, Arshad M, Aslam M, Gündüz D, Weyand M, Micoogullari M, Abdallah Y, Piper HM, Noll T. Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells. Am J Physiol Cell Physiol 2010;298:C1501-9. [PMID: 20200209 DOI: 10.1152/ajpcell.00333.2009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
3 Scharbrodt W, Abdallah Y, Kasseckert SA, Gligorievski D, Piper HM, Böker DK, Deinsberger W, Oertel MF. Cytosolic Ca2+ oscillations in human cerebrovascular endothelial cells after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:57-65. [PMID: 18698333 DOI: 10.1038/jcbfm.2008.87] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
4 Radnai B, Antus C, Racz B, Engelmann P, Priber JK, Tucsek Z, Veres B, Turi Z, Lorand T, Sumegi B, Gallyas F Jr. Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation. Mol Cancer 2012;11:34. [PMID: 22583868 DOI: 10.1186/1476-4598-11-34] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
5 Semighini CP, Harris SD. Regulation of apical dominance in Aspergillus nidulans hyphae by reactive oxygen species. Genetics 2008;179:1919-32. [PMID: 18689883 DOI: 10.1534/genetics.108.089318] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 8.9] [Reference Citation Analysis]
6 Wu MM, Lou J, Song BL, Gong YF, Li YC, Yu CJ, Wang QS, Ma TX, Ma K, Hartzell HC, Duan DD, Zhao D, Zhang ZR. Hypoxia augments the calcium-activated chloride current carried by anoctamin-1 in cardiac vascular endothelial cells of neonatal mice. Br J Pharmacol 2014;171:3680-92. [PMID: 24758567 DOI: 10.1111/bph.12730] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
7 Durante M, Sgambellone S, Lanzi C, Nardini P, Pini A, Moroni F, Masini E, Lucarini L. Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice. Front Pharmacol 2019;10:525. [PMID: 31164820 DOI: 10.3389/fphar.2019.00525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Aley PK, Bauer CC, Dallas ML, Boyle JP, Porter KE, Peers C. Hypoxic Modulation of Ca2+ Signaling in Human Venous and Arterial Endothelial Cells. J Membrane Biol 2009;227:151-8. [DOI: 10.1007/s00232-008-9147-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Shackelford RE, Li Y, Ghali GE, Kevil CG. Bad Smells and Broken DNA: A Tale of Sulfur-Nucleic Acid Cooperation. Antioxidants (Basel) 2021;10:1820. [PMID: 34829691 DOI: 10.3390/antiox10111820] [Reference Citation Analysis]
10 Huang D, Wang Y, Wang L, Zhang F, Deng S, Wang R, Zhang Y, Huang K. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell. PLoS One 2011;6:e27123. [PMID: 22073128 DOI: 10.1371/journal.pone.0027123] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
11 Mao H, Lockyer P, Townley-Tilson WH, Xie L, Pi X. LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation. Arterioscler Thromb Vasc Biol 2016;36:350-60. [PMID: 26634655 DOI: 10.1161/ATVBAHA.115.306713] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
12 Moroni F, Chiarugi A. Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment: PARP-1 and the ischemic neurovascular unit. FEBS Journal 2009;276:36-45. [DOI: 10.1111/j.1742-4658.2008.06768.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
13 Martínez-romero R, Cañuelo A, Siles E, Oliver FJ, Martínez-lara E. Nitric oxide modulates hypoxia-inducible factor-1 and poly(ADP-ribose) polymerase-1 cross talk in response to hypobaric hypoxia. Journal of Applied Physiology 2012;112:816-23. [DOI: 10.1152/japplphysiol.00898.2011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
14 Zhao K, Ju Y, Li S, Altaany Z, Wang R, Yang G. S-sulfhydration of MEK1 leads to PARP-1 activation and DNA damage repair. EMBO Rep 2014;15:792-800. [PMID: 24778456 DOI: 10.1002/embr.201338213] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 9.9] [Reference Citation Analysis]
15 Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway. J Cell Mol Med 2017;21:324-35. [PMID: 27704718 DOI: 10.1111/jcmm.12967] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
16 Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection. Clin Mol Hepatol 2019;25:65-73. [PMID: 30798587 DOI: 10.3350/cmh.2018.0070] [Reference Citation Analysis]
17 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]